Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP Facebook

The following are excerpts from the newsletter


March 13, 1996

  • Prevention of adverse drug events caused by potassium phosphate injection
  • Effective date of FDA's Medical Device Regulations extended
  • "T.I.W." - a dangerous medical abbreviation
  • Action forthcoming on Versed (midazolam) labeling
  • Another error reported with esmolol (BREVIBLOC)
  • Safety Briefs:
    • Check for outdated medications and supplies
    • Vincristine regimen written incorrectly
    • Caution: storage of epinephrine 30 mL vials in clinical areas
    • Listen to patients!

March 27, 1996

  • Use of nitroglycerin ointment as alternative to phentolamine for dopamine extravasation
  • 649 children given diluted vaccine by pediatrician
  • Avoid abbreviating drug names in medical orders
  • Preventing pediatric adverse drug events by a dose verification process
  • Drug sampling - Now there's a better way
  • ISMP announces availability of medication safety fellowship.
  • Safety Briefs:
    • If you dial an incorrect number for a fax transmission, confidential information might wind up in the wrong hands.
    • Name watch: Tiazac® and Ziac®
    • Quite a few people have been fooled by the new packaging used for Cepacol® lozenges.
    • Reports increase involving replacement of incorrect medications into automated dispensing modules

subscribe now

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Newsletter Editions
Acute Care
Long Term Care
ISMP 17th Annual Cheers Awards
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2015 Institute for Safe Medication Practices. All rights reserved